Elucidating the specific pharmacological mechanism of action (MOA) of naturally happening compounds can be complicated. While Tarselli et al. (60) designed the first de novo artificial pathway to conolidine and showcased this Normally occurring compound properly suppresses responses to both of those chemically induced and inflammation-derived pain,… Read More